Literature DB >> 12366781

Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population.

T Takada1, E Suzuki, K Morohashi, F Gejyo.   

Abstract

Interleukin-18 (IL-18) and interleukin-12 (IL-12) synergistically stimulate interferon-gamma (IFN-gamma) production from Th1 cells. The levels of serum IL-18 and IFN-gamma and bronchoalveolar lavage fluid IL-18 were elevated in patients with sarcoidosis. The polymorphisms of the IL-18 gene may play a possible role in expression regulation of the gene. We investigated the roles of the polymorphisms in the development of sarcoidosis. We examined two single nucleotide polymorphisms of the IL-18 gene in 119 patients with sarcoidosis and 130 healthy control subjects. Our results showed that the frequency of sarcoidosis patients with the CA genotype at position -607 was significantly higher than that with the AA genotype (OR = 2.200) and a significantly higher proportion of patients had the C allele at -607 compared with that of the controls (OR = 2.123). No significant differences were seen in the distribution of the genotypes or phenotype frequencies at position -137. There was no specific organ involvement associated with a certain genotype or phenotype. In IL-18 gene polymorphisms, the C allele at position -607 might be a genetic risk factor for sarcoidosis in this Japanese population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12366781     DOI: 10.1034/j.1399-0039.2002.600105.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  13 in total

Review 1.  Genetics of sarcoidosis: candidate genes and genome scans.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki
Journal:  Proc Am Thorac Soc       Date:  2007-01

2.  Role of genetic polymorphisms in ACE and TNF-alpha gene in sarcoidosis: a meta-analysis.

Authors:  Igor Medica; Andrej Kastrin; Ales Maver; Borut Peterlin
Journal:  J Hum Genet       Date:  2007-09-04       Impact factor: 3.172

3.  Genetic polymorphisms of IL-18 rs1946518 and IL-1β rs16944 are associated with prognosis and survival of acute myeloid leukemia.

Authors:  Hong Wang; Mingqiang Hua; Shukang Wang; Jie Yu; Chen Chen; Xueyun Zhao; Chen Zhang; Chaoqin Zhong; Ruiqing Wang; Na He; Ming Hou; Daoxin Ma
Journal:  Inflamm Res       Date:  2016-12-07       Impact factor: 4.575

4.  Genetic polymorphism of interleukin-18 gene promoter region in rheumatoid arthritis patients from southern India.

Authors:  Varun Chaithanya Gurram; Sunil Kumar Polipalli; Vijay Kumar Karra; Madhavi Puppala; Sanjeev Kumar Pandey; Seema Kapoor; Ashok Kumar; Sudhakar Godi
Journal:  J Clin Diagn Res       Date:  2014-06-20

5.  Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population.

Authors:  Ping-An Zhang; Jian-Min Wu; Yan Li; Xiang-Sheng Yang
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

6.  Interleukin-18 is increased only in a minority of patients with active Crohn's disease.

Authors:  C Schmidt; T Giese; R Goebel; M Schilling; T Marth; A Ruether; S Schreiber; S Zeuzem; S C Meuer; A Stallmach
Journal:  Int J Colorectal Dis       Date:  2007-02-21       Impact factor: 2.571

7.  Association of polymorphisms of interleukin-18 gene promoter region with polycystic ovary syndrome in chinese population.

Authors:  Yan Yang; Jie Qiao; Mei-Zhi Li
Journal:  Reprod Biol Endocrinol       Date:  2010-10-22       Impact factor: 5.211

Review 8.  Idiopathic giant cell myocarditis and cardiac sarcoidosis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

9.  Genetic polymorphisms and susceptibility to lung disease.

Authors:  Pauline L Lee; Carol West; Karen Crain; Lei Wang
Journal:  J Negat Results Biomed       Date:  2006-04-11

10.  Interleukin 18 promoter variants (-137G>C and -607C>A) in patients with chronic hepatitis C: association with treatment response.

Authors:  Stephan L Haas; Christel Weiss; Peter Bugert; Jutta Gundt; Heiko Witt; Manfred V Singer; Thomas Berg; Ulrich Böcker
Journal:  J Clin Immunol       Date:  2009-05-20       Impact factor: 8.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.